Sangamo Biosciences's market cap is currently $239.94M. The company's EPS TTM is $-0.745; its P/E ratio is ―; Sangamo Biosciences is scheduled to report earnings on February 19, 2025, and the estimated EPS forecast is $-0.09. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 176.23M	$ 111.30M	$ 110.70M	$ 118.19M	$ 102.43M
Gross Profit	$ -45.33M	$ 99.19M	$ 101.26M	$ -62.45M	$ -43.49M
Operating Income	$ -274.00M	$ -201.28M	$ -183.34M	$ -129.55M	$ -105.18M
EBITDA	$ -87.43M	$ -189.17M	$ -173.90M	$ -123.87M	$ -101.25M
Net Income	$ -257.83M	$ -192.28M	$ -178.30M	$ -121.12M	$ -75.82M
Balance Sheet
Cash & Short-Term Investments	$ 81.00M	$ 277.63M	$ 464.72M	$ 691.95M	$ 384.99M
Total Assets	$ 165.32M	$ 562.51M	$ 721.92M	$ 938.55M	$ 637.52M
Total Debt	$ 38.10M	$ 43.11M	$ 48.08M	$ 42.09M	$ 44.41M
Net Debt	$ -7.10M	$ -57.34M	$ -130.79M	$ -89.24M	$ -36.02M
Total Liabilities	$ 82.43M	$ 267.55M	$ 346.58M	$ 441.18M	$ 204.78M
Stockholders' Equity	$ 82.89M	$ 294.96M	$ 375.34M	$ 497.37M	$ 432.74M
Cash Flow
Free Cash Flow	$ -246.00M	$ -243.80M	$ -256.53M	$ 155.16M	$ -165.08M
Operating Cash Flow	$ -224.84M	$ -223.63M	$ -233.25M	$ 169.88M	$ -144.40M
Investing Cash Flow	$ 153.53M	$ 59.28M	$ 248.20M	$ -271.63M	$ -59.80M
Financing Cash Flow	$ 14.59M	$ 84.66M	$ 32.86M	$ 153.10M	$ 142.03M

Currency in USD

Sangamo Biosciences Earnings and Revenue History

Income Statement >

Sangamo Biosciences Debt to Assets

Balance Sheet >

Sangamo Biosciences Cash Flow

Cash Flow >

Sangamo Biosciences Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing